Thomas Sciascia - Chief Scientific Officer at Trevi Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
TRVI on Nasdaq
All Insider Reports
All Insider Reports

Thomas Sciascia - trading volume in the past year for Trevi Therapeutics, Inc.

Holdings reported by Thomas Sciascia for Trevi Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 220K $653K $2.96 Aug 19, 2024 Direct
Stock Option (right to buy) 0 Aug 19, 2024 Direct Common Stock

Transactions reported by Thomas Sciascia for Trevi Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.